alt="syringe"

Designing Tomorrow´s Vaccines

SVF develops vaccines and immunotherapies to prevent and treat life-threatening diseases based on technology developed at the Karolinska Institute in Stockholm. A therapeutic vaccine for chronic hepatitis B and D infection, and a prophylactic vaccine targeting both the current COVID-19 pandemic and other coronavirus infections.

Testimonials

“The world is now more aware than ever of the transformative power of effective vaccines, and I’m very excited by the potential of SVF’s vaccine portfolio”

Richard Bethell

CEO